| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.081 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |